Cyclo Therapeutics Inc. Gains 29.01%

Wed, Nov 08, 2023 at 07:25 PM

Cyclo Therapeutics Inc. (CYTH:NASDAQ) soared at $1.69, representing a gain of 29%. On Wed, Nov 08, 2023, CYTH:NASDAQ hit a New 2-Week High of $1.69. The stock got featured on our News Catalysts scanner on Thu, Nov 02, 2023 at 07:53 AM in the 'INSIDER' category. From Wed, Oct 25, 2023, the stock recorded 60.00% Up Days and 45.45% Green Days

About Cyclo Therapeutics Inc. (CYTH:NASDAQ)

Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease.

Top 10 Gainers:

Peraso Inc. (PRSO:NASDAQ), 110.84%
GAN plc (GAN:NASDAQ), 82.78%
Korro Bio, Inc. (KRRO:NASDAQ), 68.16%
Heart Test Laboratories, Inc. (HSCS:NASDAQ), 53.38%
Tenon Medical Inc. (TNON:NASDAQ), 49.79%
Porch Group Inc. (PRCH:NASDAQ), 34.35%
Fitell Corporation (FTEL:NASDAQ), 34.15%
Senti Biosciences Inc Com (SNTI:NASDAQ), 30.77%
Blade Air Mobility Inc. (BLDE:NASDAQ), 29.52%
Cyclo Therapeutics Inc. (CYTH:NASDAQ), 29.01%